| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 168.84B | 177.49B | 168.17B | 167.04B | 157.38B | 140.84B |
| Gross Profit | 40.01B | 45.71B | 39.65B | 37.66B | 37.49B | 32.15B |
| EBITDA | 19.83B | 24.29B | 22.78B | 24.29B | 22.98B | 17.68B |
| Net Income | 5.25B | 9.83B | 4.88B | 7.49B | 6.80B | 5.71B |
Balance Sheet | ||||||
| Total Assets | 208.36B | 228.58B | 203.48B | 209.91B | 193.23B | 180.96B |
| Cash, Cash Equivalents and Short-Term Investments | 29.00B | 33.68B | 26.18B | 32.54B | 30.58B | 28.81B |
| Total Debt | 42.22B | 39.58B | 40.40B | 40.57B | 35.47B | 32.13B |
| Total Liabilities | 83.11B | 85.96B | 80.96B | 84.24B | 80.30B | 77.86B |
| Stockholders Equity | 116.23B | 133.06B | 113.83B | 116.76B | 104.42B | 94.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.17B | 3.04B | 6.59B | 3.88B | 6.60B |
| Operating Cash Flow | 0.00 | 22.04B | 13.69B | 17.74B | 12.32B | 12.24B |
| Investing Cash Flow | 0.00 | -8.77B | -10.44B | -12.03B | -8.05B | -6.84B |
| Financing Cash Flow | 0.00 | -8.25B | -8.31B | -6.41B | -3.17B | -11.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥293.65B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
76 Outperform | ¥101.42B | 0.96 | ― | 1.43% | 8.02% | 1762.59% | |
71 Outperform | ¥107.58B | 14.92 | ― | 4.64% | 1.98% | -17.68% | |
70 Outperform | ¥140.05B | 13.12 | ― | 3.88% | 5.54% | 101.81% | |
70 Outperform | ¥163.74B | 4.15 | 8.17% | 2.04% | 1.06% | 72.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | ¥18.57B | 124.61 | ― | ― | -8.87% | ― |